Research RFinding: HPV Vaccine in Men Would Save Costs of Treating Throat Cancer

On April 15, 2015, in Blog, H News, by Admin

US News & World Report: A new study shows that giving men Gardasil is cost-effective and prevents throat cancer. Controversy over the HPV vaccine has centered on its risks to girls and the idea that protecting them against cervical cancer could also lead them to experiment with sex at a younger age. But a new study […]

Tagged with:  

New Thinking About Herpes Vaccine Design

On March 13, 2015, in Blog, H News, by Admin

A new way of thinking challenges standard notions about what a herpes vaccine should look like. New thinking about vaccine design has helped researchers forge ahead in developing a potential vaccine. Herpes simplex virus infections are an enormous global health problem and there is currently no viable vaccine. For nearly three decades, immunologists’ efforts to […]

Tagged with:  

Harvard: HIV Inhibitor May Also Block Herpes Simplex Virus

On July 28, 2014, in Blog, H News, by Admin

Harvard Medical School – July 25, 2014 Herpes viruses are stubborn foes. Infections from this family of viruses last a lifetime,causing suffering and even death when dormant viruses come to life. Herpes virus infections also increase the risk of spreading or acquiring HIV. Cells infected with herpes simplex virus. Image: Y tambe via Wikimedia Commons […]

Notes from the Floor: 39th International Herpesvirus Workshop (Kobe, Japan)

On July 22, 2014, in Blog, H News, by Admin

    Notes from members of ProjectAccept.org’s advisory council     Vaccine Strategy: David Knipe is working with Sanofi on an HSV-2 vaccine; it’s a live, attenuated strain (deleted in a number of genes). Right now, he showed protection from primary infection in mice, and he’s answering a question right now about it being much […]

Agenus Vaccine Trials Show Promise

On July 8, 2014, in Blog, H News, by Admin

Agenus Vaccine Shows Significant Reduction in Viral Burden After HerpV Generated Immune Activation Phase 2 trial in patients with genital herpes shows correlation between viral load reduction and CD8 T cell activation, an important clinical surrogate Trial shows booster shot demonstrates sustainable, long-term effect Lexington, MA – June 26, 2014 Agenus Inc. (Nasdaq: AGEN), an […]

 

The Mexican HPV ‘Cure’: How Do You Say “Quack” in Spanish?

On July 22, 2013, in Blog, H News, by Admin

Dr. Ricardo Rosales down at Virolab in Mexico claims to have the cure to HPV, and even cervical cancer. His company, Virolab, attempted a few years ago to open shop in the US – even going so far as to pop up a shell company in California and file with the Securities Exchange Commission (SEC) […]

Tagged with:  

Study Finds Protein Link to Sexually Transmitted Disease Susceptibility

On March 9, 2013, in Blog, H News, by Admin

Study finds protein link to sexually transmitted disease susceptibility From MedicalXpress February 28, 2013 in Diseases, Conditions, Syndromes It is estimated that 450 million people worldwide are newly infected with STIs each year. Chlamydia has the highest infection rate of all the STIs reported in Australia. The research, published today in the prestigious journal, Science, […]

 

Join the H Community

Click to connect with the community for support, social and more!

Connect

Please Donate. We need your help!

To make a secure donation to ProjectAccept.org via PayPal:
ProjectAccept.org is a registered 501c3 Non-Profit

Share your H Story

Share your story and help us declare checkmate on STDs! (you can remain as anonymous as you'd like)

Click here to begin!

Subscribe via Email

Enter your email address to subscribe to ProjectAccept.org and receive notifications of new posts by email.

Site Notices

© 2012-2014, ProjectAccept.org (some images copyright (c) 123RF Stock Photos)

ProjectAccept.org is a Virginia Non-Stock Corporation, registered with the United States government as a 501c3 non-profit. To verify our IRS standing, Click Here

For more information, including our timeline & milestones, please see our About page.

The ProjectAccept.org website is managed and maintained by The Rask Group